As part of NextPharma’s ongoing strategy to continue to invest in its existing sites, in order to both increase capacity and to improve efficiency with modern state-of-the-art equipment, the European contract development and manufacturing organization (CDMO) recently completed a €15 million investment at its Goettingen, Germany site. The investment project, which was completed within 12 months, expands NextPharma’s existing capacity in manufacturing and packaging of oral solid dosage forms.   ...